Managing Contrast Reactions

1. What contrast agent was administered? (Default: Identify specific agent, dose, and route)
2. What type of reaction occurred? (Default: Classify as allergic-like, physiologic, or vasovagal)
3. When did symptoms begin relative to injection? (Default: Document onset time)
4. What symptoms did the patient exhibit? (Default: Document all signs and symptoms)
5. What treatment was administered? (Default: Document all interventions)
6. What was the patient outcome? (Default: Resolved, transferred, admitted)

Documents to Request

• Contrast administration record (agent, dose, rate, route)
• Patient allergy history and prior contrast reaction documentation
• Vital signs at baseline and during/after reaction
• Medication administration record for treatment given
• Patient medical history (asthma, cardiac disease, beta-blocker use)
• ACR Manual on Contrast Media (current edition) — department copy

Step 1: Classify the Reaction

ACR Reaction Classification

Timing Classification

Step 2: Execute Treatment Protocol

Mild Reactions

Moderate Reactions

Severe Reactions — Call Code/Rapid Response

Critical points:

• Epinephrine IM (1:1000, 0.3 mg) is the first-line treatment for anaphylaxis — do not delay
• Beta-blocker patients may require glucagon 1–5 mg IV if epinephrine is ineffective
• IV epinephrine (1:10,000) is reserved for cardiac arrest or refractory anaphylaxis with IV access

Step 3: Document the Reaction

Required Documentation Elements

Documentation Template

CONTRAST REACTION REPORT
Agent: [name] [concentration] [volume] [route]
Time of injection: [HH:MM]
Reaction onset: [HH:MM] ([X] minutes post-injection)
Symptoms: [list all symptoms chronologically]
Severity: [Mild/Moderate/Severe] [Allergic-like/Physiologic]
Treatment: [medication, dose, route, time] for each intervention
Response: [symptoms resolved at HH:MM / transferred / admitted]
Provider: Dr. [Name]
EMR allergy flag updated: Yes/No
Patient education provided: Yes/No
Premedication plan documented for future studies: Yes/No

Step 4: Plan for Future Studies

Premedication Protocols

Decision Matrix for Future Contrast Studies

Step 5: Department Preparedness Requirements

Emergency Equipment Checklist

Checkpoint B: Post-Draft Alignment (Mandatory)

1. Is the reaction correctly classified by severity and type (ACR framework)?
2. Was treatment appropriate for the reaction severity?
3. Is the EMR allergy flag updated with reaction details?
4. Is a premedication plan documented for future contrast studies?
5. Is the reaction report complete with all required elements?

Quality Audit

• Contrast agent, dose, and route are documented
• Reaction onset time is recorded relative to injection
• Symptoms are listed chronologically
• Severity is classified per ACR Manual on Contrast Media
• Type is classified (allergic-like vs. physiologic vs. vasovagal)
• Treatment medications include dose, route, and administration time
• Outcome is documented (resolved, transferred, admitted)
• EMR allergy flag is updated with specific contrast agent and reaction details
• Premedication protocol is specified for future studies
• Patient education was provided regarding the reaction and future risks
• Institutional adverse event reporting system is notified
• Emergency equipment checklist is current for the scanner room
• Staff contrast reaction training is documented and current

Guidelines

1. Epinephrine IM is the first-line treatment for anaphylaxis — every second of delay worsens outcomes; do not substitute with diphenhydramine or steroids as first-line.
2. Always update the EMR allergy flag with the specific contrast agent, reaction type, and severity — vague flags like "contrast allergy" are insufficient.
3. Premedication reduces but does not eliminate the risk of repeat reactions — document the residual risk in the informed consent discussion.
4. Physiologic reactions (nausea, warmth, metallic taste) do not require premedication for future studies; document as "physiologic" in the allergy history to avoid unnecessary premedication.
5. Patients on beta-blockers may have refractory anaphylaxis — have glucagon available and flag these patients during pre-screening.
6. The 13-hour premedication protocol has the strongest evidence; the accelerated and emergency protocols have reduced efficacy and should be used only when the study cannot wait.
7. Report all moderate and severe reactions through the institutional adverse event reporting system; mild reactions should be documented in the medical record at minimum.